Hyper-Transmissible SARS-CoV-2 Variant Detected in United States Wastewater

▴ Hyper-Transmissible SARS-CoV-2 Variant Detected in United States Wastewater
GT Molecular, a leader in wastewater-based epidemiological testing, has reported the detection of hyper-transmissible SARS-CoV-2 from the B.1.1.7 lineage in three wastewater treatment plants in the United States.

GT Molecular, a leader in wastewater-based epidemiological testing, has reported the detection of hyper-transmissible SARS-CoV-2 from the B.1.1.7 lineage in three wastewater treatment plants in the United States. This is an additional piece of evidence that the UK variant or a UK variant-like strain is spreading in the United States. GT Molecular detected the strain using its highly sensitive digital PCR test for the SARS-CoV-2 virus. This test is available immediately both as a fee-for-service and as a complete, ready-to-use PCR kit for testing labs.

"Molecular biologists from around the world have come together to advance wastewater-based epidemiological approaches over the last year. This is an excellent demonstration of the power of these approaches, wherein an entire community can be tested for the presence of a variant in a single sample in a matter of hours," says, Dr. Rose Nash, Director of R&D at GT Molecular.

GT Molecular will continue to screen communities around the country for the presence of this variant in their community wastewater through their nationwide wastewater testing program. Additionally, GT Molecular will provide the molecular reagents they designed and optimized for this analysis to the greater wastewater-based epidemiology community.

"Our team continues to respond rapidly to this pandemic by releasing both a fee-for-service test for communities and an all-in-one PCR kit for testing labs for this dangerous variant," says GT Molecular CEO Christopher McKee. "Our new analysis will allow communities and testing labs to quickly determine whether the SARS-CoV-2 B.1.1.7 variant is present while giving health officials timely data to make decisions that can better help manage outbreaks."

About GT Molecular

Whether for cancer, GMO, or harmful pathogens, GT Molecular (GTM) is a leader in providing highly customizable, ultrasensitive digital PCR and qPCR tests for researchers and the Molecular Diagnostics community. GTM's molecular app technology is an easy-to-use, end-to-end solution for rapid deployment and provides reliable and consistent measurements while detecting as little as 1-3 molecules of target nucleic acid.

Tags : #GTMolecular #UnitedStates #CovidInfection #Hyper-TransmissibleSARS-CoV-2Variant #wastewaterTreatmentplants #SARS-CoV-2virus #PCRKITS #Covid-19

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026